OPPORTUNITY: Meet with Pharma Industry/Investors at UW

July 18th, 2024

Context: We at UW are hosting pharma companies  and a few investors for our UW Emerging Life Science Biopartnering event. UW teams whose innovation/research relates to discovery stage therapeutics, AI in pharma, or enabling life science innovations are encouraged to participate by pitching to and then meeting with industry/investor guests. What: Private meeting track: 5-minute lightning pitch followed by a series of 8 to 10 private 15-minute meetings with visiting companies/investors.
Where: UW Husky Union Building (HUB)

How to apply: Complete the application form linked here. Questions? Contact Rad Roberts at rad@uw.edu 

Venture Analyst Positions at Washington Research Foundation 

Applications Due June 16, 2024, 5pm PDT 

Washington Research Foundation is a leading funder of innovations in the life sciences sector in Washington State, dedicated to transforming innovative research into marketable solutions that enhance human health and well-being.  We are seeking highly talented and communicative Venture Analysts to join our team.  The ideal candidate will have a robust scientific or business background coupled with a keen interest in technology commercialization. Location: Remote or Eastlake neighborhood, Seattle, WA |Compensation: $35/hour Learn more and apply >>>  

NSF I-CORPS | Powered By Co-Motion

Apply by June 10 – Space is limited!  Customer Discovery Program. Do you have an idea that you think has commercial potential but you're unsure if there's a market for it? Then apply now for CoMotion's I-Corps program, and seize the opportunity to better understand your customer and expand your entrepreneurship knowledge and skills. Learn more and apply >>> 

SP3NW Startup Advisor Lunch & Learn Series: MedTech Regulatory Pathway 
June 11, 2024, 11:30am - 1:00pm PDT 

Free, Hybrid - Spokane, WA 
 
SP3NW supports the necessary infrastructure for a flexible startup ecosystem by hosting events that bring together academia, industry, entrepreneurs, innovators, funders, and ecosystem partners. This helps to identify, grow, and deploy emerging innovations through wraparound startup incubation services. 
 
Rich Wynkoop of Vision28 will be discussing the MedTech regulatory pathway during this month's Lunch & Learn. He is a seasoned executive who takes a pragmatic approach to quality management, regulatory affairs, and compliance to help clients achieve cost-effective and successful outcomes.   

Grant Program Information Sessions

June 12, 3-3:30 pm PDT, virtual. Washington Competes Grant information session 

June 12 3:30-4 pm PDT, virtual. SBIR/STTR Matching Fund Grant information session 

Ten Washington Competes grants for founders developing innovations aimed at improving the health and wellbeing of Washington citizens. and ten SBIR/STTR matching grants for researchers with Phase I awards. Grants will be prioritized for entrepreneurs in categories that have not traditionally received as much funding. Learn more! >>> 

SBIR 101 Innovation Funding

June 12, 2024 | 4:00 - 5:30 PM PDT | Free | Hybrid - Spokane, WA 

This overview of the Small Business Innovation Research (SBIR) program is intended for small businesses or startups who are developing innovative technologies and may be interested in selling that technology to federal agencies. 
 
The basics of the SBIR/STTR programs including what they are, who they are meant for, and which federal agencies participate will be covered. For background information visit SBIR.gov. 

Register >>>

Cures Within Reach RFP - Apply now!

Cures Within Reach recently launched a Request for Proposals (RFP) for clinical repurposing trials in blood cancers from anywhere in the world. Blood cancer LOIs from anywhere in the world with budgets of up to $75,000 are due on July 29. While trials in any blood cancer are eligible, CWR has a preference for trials impacting multiple myeloma and/or myelodysplastic syndrome. 

Apply today or help us spread the word! Don't let questions about deadline extensions, eligibility, budget or anything else stop you from applying. Contact Clare Thibodeaux, PhD directly for more information >>> clare@cureswithinreach.org 

Hybrid Public Workshop: Artificial Intelligence in Drug & Biological Product Development 

Aug 6, 7am – 2:30pm PDT, hybrid virtual/in-person

Join this hybrid public workshop convened by the U.S. Food and Drug Administration (FDA) in collaboration with the Clinical Trials Transformation Initiative (CTTI), on the use of AI in drug and biological product development. Learn from experts as they discuss guiding principles for the responsible use of AI in the development of safe, effective, and high-quality drugs. Drawing on real case examples, experts will discuss their rationale for particular approaches, share their methods for evaluating success, recount challenges faced, explore options for scaling and wider applicability, and outline considerations for moving forward. More information and registration >>>

NIH SEED Small Business Transition Grant Pre-Application Webinar 
Informational webinar on June 11, 2024 | 12:00 PM 

Attention research scientists interested in gaining entrepreneurial and leadership experience - attend this webinar to learn about the newly released Small Business Transition Grant for New Entrepreneurs. 

Potential applicants are encouraged to submit their questions to NIH SEED (Small business Education and Entrepreneurial Development) at SEEDinfo@nih.gov in advance of the webinar. Participation in this webinar, although encouraged, is optional and is not required for the submission of an application. 

STTR, clinical trial not allowed https://grants.nih.gov/grants/guide/pa-files/PAR-24-133.html  

STTR, clinical trial required https://grants.nih.gov/grants/guide/pa-files/PAR-24-134.html 

SBIR, clinical trial not allowed https://grants.nih.gov/grants/guide/pa-files/PAR-24-131.html 

SBIR, clinical trial required https://grants.nih.gov/grants/guide/pa-files/PAR-24-132.html 

Apply Now for 2025-2026 ITHS Pilot Awards

ITHS is happy to announce that the application period for the 2025–2026 ITHS Pilot Program awards is now open. This program offers a wonderful opportunity for investigators from the five-state WWAMI region (Washington, Wyoming, Alaska, Montana, Idaho) to receive funding to help their new research projects get off the ground. Letters of Intent for these awards are due on Tuesday, July 9, 2024.

NEW RESEARCH Funding Announcement

We are pleased to announce our partners at WE-REACH are offering a new quick turn-around funding opportunity for UW-affiliated teams that are advancing their therapeutic, device, and diagnostic life science products through key developmental milestones. Teams can apply for up to $150,000 to be used within 10 months of the award start date, which will be July 29, 2024.

DON'T MISS THE DEADLINE!

Submit the letters of intent by 5pm on Thursday June 6th, 2024 to wereach@uw.edu.

Expo 24: ITHS Symposium & Poster Session

The 2024 Expo & Symposium was a rousing success this year, attracting over 100 guests at the Center for Urban Horticulture on the east side of the University of Washington campus. The event created a vibrant atmosphere for attendees eager to explore the latest advancements in health and technology. Guests were treated to engaging talks from two keynote speakers who delved into the fascinating world of nanotechnology in medicine. Read more>>>

JOIN ITHS

Interested in becoming part of a unique catalyst that accelerates discoveries to practice? Members gain access to ITHS research services, resources, tools, training, funding, and collaboration opportunities. Become an ITHS member today › 

CONNECT WITH US ON LINKEDIN AND FOLLOW US ON TWITTER

Build your professional network and connect with us on LinkedIn. Stay up to date with the latest translational science headlines (plus the occasional adorable ITHS pet) when you connect with us on Twitter. 

SIGN UP TO RECEIVE OUR NEWSLETTER

ITHS Research Connector is our monthly newsletter with upcoming events, Education & Training Program News, Funding News, and Research Services News. Sign up and stay connected to research news. 

WHO WE ARE:

The ITHS Technology Development Center (TDC) is staffed with clinical, regulatory, and commercialization experts to assist academic and industry innovators through translation, startup formation, clinical study, regulatory clearance, fundraising, and market entry.

We welcome all for an initial consultation, in which we identify resources and define a scope of work optimized for the advancement of your small molecule, biologic, medical device, or digital health application. No matter where you are on your journey to commercialization, we can help you find the services, funding, and programs you need to move you forward.